Myasthenia gravis is a chronic neuromuscular disorder that causes skeletal muscle weakness. Typically, myasthenia gravis affects the ocular, bulbar, neck, proximal limbs, and respiratory muscles. Although the presentation is typically observed with complaints of vision and bulbar symptoms such as diplopia, dystonia, and dysphagia, this article presents a case study of an elderly man with a history of increasing upper extremity weakness with complaints of worsening hand dexterity and intermittent episodes of expressive aphasia. After cervical laminectomy with fusion, this gentleman was admitted to the medical intensive care unit, in a complete myasthenic crisis. Keywords: Myasthenia gravis crisis, Neurology, Progressive weakness [DIMENS CRIT CARE NURS. 2016;35(4):190/194] 
INITIAL PRESENTATION OF THE CASE STUDY
Mr G is a 78-year-old white man who was initially referred to the orthopedic clinic by his primary care provider. His chief complaint was progressively worsening hand dexterity over several months to the point that he could hardly write. He also complained of having to transition from a cane to a walker within the year and has now worsened to being wheelchair bound at the time of his initial visit. The week before coming to the clinic, he was admitted to the hospital related to multiple falls and trouble with verbal communications. A magnetic resonance imaging of his cervical-spine during that admission revealed he had severely degenerative cervical spondylosis, specifically with increased thoracic cord signal changes and severe stenosis to C4-5. He was subsequently admitted to the orthopedic floor of the hospital for surgical intervention and was scheduled for a posterior cervical laminectomy with fusion of C3 through T1. On hospital day (HD) 4, the surgical procedure went without incident and he was transferred to the neurological intensive care unit postoperatively for close observation.
Mr G was transferred to the surgical step-down unit late in the afternoon of HD 4 with equal bilateral strength to all extremities and an intact neurological status. Late on HD 5, because of increasing episodes of confusion and a new complaint of dyspnea, Mr G was taken for a computed tomography (CT) scan to rule out a pulmonary embolus. The scan was negative for pulmonary embolus; however, the nursing staff noted that evening that he was having difficulty with speech and swallowing.
Early on HD 6, the nursing staff activated the in-house rapid response team to assess Mr G, stating that his speech was more ''garbled,'' with increased difficulty swallowing, tachycardia (his heart rate was in the 120s), and with new complaints of difficulty breathing. Upon assessment by the rapid response team nurse and physician, Mr G was emergently transferred to the medical intensive care unit (MICU) for closer observation and possible intubation.
PATHOPHYSIOLOGY
Transmission of nerve impulses at the neuromuscular junction requires the release of adequate amounts of neurotransmitters from the presynaptic terminals of the axon and effective binding of the released neurotransmitter to the receptor sites on the membranes of muscle cells. Myasthenia gravis (MG) is a neuromuscular junction disorder caused by the binding of autoantibodies to the acetylcholine receptor (AchR) sites located on the postsynaptic membrane. The binding of these antibodies, mainly immunoglobulin G, causes a block or a complement mediated loss of AchR sites. 1 Over time, the number of AchR on the plasma membrane greatly decreases. This decrease causes diminished or blocked nerve impulse transmissions across the neuromuscular junction, incomplete depolarization, and loss of muscle cell contraction. Myasthenic crisis occurs when severe loss of muscle contraction causes extreme quadriparesis or quadriplegia, extreme difficulty in swallowing, respiratory insufficiency, and shortness of breath that, if left untreated, can lead to respiratory arrest. 1 
CLINICAL MANIFESTATIONS LABORATORY AND DIAGNOSTICS
On admission to the MICU, initial laboratory testing was unremarkable to include the arterial blood glass. Admitting vital signs showed a bladder temperature of 100.2 F, a pulse rate of 124 with underlying rhythm of atrial fibrillation, respiratory rate of 20, with increasing inspiratory difficulty, and pulse oximetry of 100% on 4 L/m oxygen (O 2 ) via nasal cannula. After initial laboratory and physical assessment, the MICU team considered MG on their differential diagnosis and ordered Ach-R antibody labs, as well as muscle-specific receptor tyrosine kinase (MuSK) antibodies.
Early on HD 7, although there was no history of MG, Mr G's 3-month history of intermittent dysarthria and coughing while eating led the MICU team to emergently consult neurology services. On initial neurology assessment, Mr G was experiencing facial weakness on cheek puff, impairment of vertical eye movements (no ptosis), and severe oropharyngeal dysphagia. The family also reported the patient was having similar episodes regarding speech and increased cough while eating and unexplained weight loss of 25 lbs over the last several months leading up to hospitalization.
Mr G was administered a Tensilon test, which showed a marked improvement with his strength of cough. According to Oh and associates, 2 a positive response is helpful, but a negative response does not exclude MG. Patient and family reported they felt there was minimal improvement in speech; however, it did remain garbled. Mr G's respiratory status continued to decline with an increase in work of breathing, negative inspiratory force (NIF) was less than j25 cm H 2 O, and thus, on HD 7, the patient was intubated for protection of his airway. Propofol (Diprivan) and Midazolam (Versed) were used for endotracheal intubation.
After intubation and stabilization of the patient, an initial CT scan of the head showed no evidence of stroke or acute process. Based upon the patient's underlying cardiac rhythm of atrial fibrillation, a bedside echocardiogram was performed to evaluate for possible thrombotic cause of symptoms; the results were an unremarkable examination.
Neurology recommended daily therapeutic plasma exchange (TPE) versus immunoglobulin G, as improvement can be seen more quickly, to be performed on a daily basis, with the overall plan to continue for 5 to 7 days per pathology's recommendation. 3 Patient's respiratory status improved after receiving 3 days of TPE, and he was successfully extubated on HD 10. Over the next several days, Mr G's respiratory status showed improvement with an upward trend in NIF values from j25 to j35 cm H 2 O. 4 Neurology recommendations were to avoid medications that can worsen MG symptoms such as steroids, "-blockers, aminoglycosides, and fluoroquinolones (Table 1) .
On HD 11, the patient continued to show moderate improvement with neurologic deficits and successfully maintained his airway with daily plasma exchange therapies. However, Mr G was continuing to exhibit a weak cough and dysarthria.
On HD 13, the plasma exchange course of therapy was completed, AchR antibody assay results were negative and MuSK antibodies were still pending. Therefore, starting Mestinon (pyridostigmine) was debated within the care team, with the final decision being to wait at this time for a more conclusive diagnosis of MG. Magnetic resonance imaging of C-spine was performed, which showed no additional pathology other than the recent surgical procedure. Chest CT was performed to evaluate for possible thyoma; the examination result was negative.
On HD 15, Mr G had shown a slight improvement in respiratory status with TPE. His NIF was j35(cm H 2 O) measured via mouthpiece. Mr G was not showing major improvement in speech and swallowing ability. He had complaints of muscle weakness to his arms, but this was felt to be part of his recovering from his cervical laminectomy. The medical and neurology team, along with consultation with the patient and his family, began a trial of Mestinon 30 mg TID, with close monitoring of cholinergic side effects. On HD 16, after receiving just 3 doses of Mestinon, Mr G was already showing clinical improvement, as evidenced by decreased dysarthria, improvement in arm strength, and no cholinergic side effects.
Mr G continued to show physical improvement while on Mestinon, and on HD 18, Mr G transferred out of the MICU. Given the patient's clinical improvement with the Mestinon, MG was diagnosed.
DISCUSSION OF LITERATURE
This case study presents the history, clinical symptoms, diagnosis, and treatment of MG in a postoperative cervical spinal fusion patient. Myasthenia gravis is a relatively uncommon disorder; however, it is 1 of the most common disorders of neuromuscular transmission. 5 The cardinal features of MG is fluctuating ocular, bulbar, respiratory, and skeletal muscle weakness, often with true muscle fatigue. The fatigue is manifested by worsening contractile forces of the muscles, not a sensation of tiredness. Patients with MG will present with complaints of specific muscle weakness and not with complaints of generalized muscle fatigue. 6 According to published literature, the incidence of MG is 0.25 to 2 per 100 000 population. 7 Myasthenia gravis occurs at any age, but according to the literature, there tends to be 2 separate peaks of time with which MG is diagnosed. These are women 20 to 30 years of age, followed by men who are often 60 years or older when their disease presents. 7 Reported rates of MG being diagnosed has risen, but this is more likely attributed to identification of those individuals and also that the population is living longer. 6 When MG or a myasthenia crisis occurs, the individual can experience many different possible symptoms or chief complaints at presentation (see Table 2 , which provides a comparison of clinical symptom manifestations and Mr G's clinical presentation). Clinical manifestations that seem to be constant in MG are fluctuating fatigue of skeletal muscles, often involving bulbar or extrinsic ocular muscles. 8 When a MG crisis occurs, the presentation is generally different for each individual patient. However, the common factor will be bulbar signs of either respiratory insufficiency or dysphagia. 9 The mortality rate of MG crisis has gone down from greater than 40% in the 1960s to 5% to 10% in the 1970s with the development of intensive care techniques and the use of immune modulatory therapies, such as plasmapheresis or intravenous human immunoglobulin. 10 A MG crisis can be triggered by many factors, such as infection, surgery, pharmaceutical causes (Table 1) , decreasing the dose or frequency of immunosuppressive medication, extreme heat, or missed doses of MG medications.
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Regardless of the cause of the MG crisis, emergent respiratory support is paramount to the patient's survival. Additional treatment options are the use of anticholinesterase drugs, steroids, immunosuppressant drugs, azathioprine, and cyclosporine used to treat MG and myasthenia crisis.
KEY ISSUES FOR THE CRITICAL CARE NURSE
Myasthenia crisis is an emergency situation that is characterized by respiratory failure related to weakness of the respiratory drive and/or diaphragm function. Myasthenia Medications That May Unmask or Exacerbate Myasthenia Gravis crisis may lead to intubation or delayed extubation especially when neuromuscular blocking agents or certain antibiotic classes are given before MG is suspected. It may also occur if these medication groups are given when MG has already been diagnosed or is suspected. (Table 1 ).
The patient may begin to show signs of respiratory distress and increased dyspnea as his/her condition deteriorates along with hypophonia, dysphagia, difficulty coughing or clearing secretions, increased respiratory rate with shallow breathing, use of accessory muscles, and abdominal breathing. The respiratory muscles should be assessed by measuring the patient's vital capacity and maximal inspiratory pressure also known as NIF. Elective intubation should be considered with patients who meet 1 or both of the criteria of the vital capacity of less than 15 to 20 mL/kg or an NIF less than 25 to 30 cm H 2 O. Patients who are expected to recover quickly may benefit from a noninvasive positive pressure ventilation. Noninvasive positive pressure ventilation may lead to further complications, with patients suffering from severe dysphagia, retention of respiratory secretions, and with an inadequate cough related to increased risk of aspiration. Therefore, precaution should be used when considering using noninvasive positive pressure ventilation. Weak cough and inability to expel secretions may lead to an increase risk of aspiration and also an increase incident of pneumonia that can then exacerbate the MG. The critical care nurse's role in the management of a patient with MG is to maintain diligence in monitoring respiratory function.
After the initial phase of care for the MG patient is underway, it would be best to have speech therapy perform a full evaluation of bulbar weakness by assessing the strength and coordination of the patient's ability to swallow throughout hospital stay and will also need to monitor closely for signs and symptoms of aspiration. Once an evaluation is performed, a complete nutrition assessment needs to be performed to evaluate if there is an adequate amount of caloric intake as a fluid consumption for the individuals. Difficulty with oral movement of a food bolus can be present with bulbar weakness.
The care team members should be diligent when addressing the pharmaceutical warnings for patients who have known MG or are being suspected of having MG (Table 1) . Unexplained increase in muscle weakness with activity or difficulty with speech in the absence of any other cause should be evaluated for MG. However, in Mr G's case, his cervical disc herniation initially seemed to explain his arm weakness and his difficulty with speech and swallow. After surgical repair of his herniation was ineffective in correcting his presenting symptoms, MG was considered as a differential diagnosis.
Emotional support of the family during the initial critical state of their family member was accomplished by the constant reassurance of the medical team. Reassurance that his current physical state may not necessarily be the final state of this individual's life, although good to hear, was frustrating for the patient and his family. Their frustration stemmed from the slow progression back toward his preadmission state of health. The family in this case was obviously concerned and at the same time supportive and caring of their loved one. They were entirely receptive and appreciative to the staff caring for their loved one. As Mr G. progressed and was able to leave the MICU to the medical-surgical ward, the family was beginning to see improvements in him.
CONCLUSION OF CARE
Mr G, diagnosed with MG, was sero-negative and MuSK negative for MG. His postoperative recovery from his cervical laminectomy was complicated by increasing complaints of cough and dystonia. Mr G was eventually discharged to a rehabilitation unit with an unknown potential to return to his previous baseline. As health care providers, the team felt that perhaps we and the family were quick to relate the patient's symptoms to the aging process or relate his symptom to his cervical stenosis and/or postoperative recovery. However, by reviewing the MG literature for this case study, the team learned and took comfort knowing that the clinical care of this individual was within the current clinical parameters for the standard of care for treatment of this particular individual. The diagnosis of MG frequently is often delayed from the initial presentation of symptoms, but it should always be in the back of our mind when we are evaluating ''progressive muscle weakness'' with difficulty in speech and swallowing.
